Impact of exercise timing on blood sugar control in adolescents with type 1 diabetes
Effets du Rythme Circadien Sur la régulation glycémique Lors d'Exercices modérés Continus et Intermittents Intenses Chez Des Adolescents Vivant Avec le diabète de Type 1
This study is testing how different times and types of exercise can help teenagers with type 1 diabetes keep their blood sugar levels stable.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 18 (estimated) |
| Ages | 10 Years to 16 Years |
| Sex | All |
| Sponsor | Lille University Academic / other |
| Locations | 1 site (Loos, Nord) |
| Trial ID | NCT06803446 on ClinicalTrials.gov |
What this trial studies
This interventional study investigates how the timing and type of exercise affect glycemic regulation in adolescents aged 10 to 16 living with type 1 diabetes. Participants will engage in either continuous or intermittent exercise sessions scheduled in the morning or afternoon. The study aims to determine the optimal exercise conditions for maintaining stable blood glucose levels during and after physical activity. It is a randomized, controlled trial conducted at a single center, focusing on minimal risks and constraints for participants.
Who should consider this trial
Good fit: Ideal candidates are adolescents aged 10 to 16 with type 1 diabetes for at least one year and an HbA1c of 12% or lower.
Not a fit: Patients with significant microvascular complications or other serious medical conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved exercise guidelines for adolescents with type 1 diabetes, enhancing their glycemic control.
How similar studies have performed: While studies on exercise and diabetes management exist, this specific focus on circadian rhythm and exercise type in adolescents is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Children and adolescents aged 10 to 16; * Living with type 1 diabetes for at least 1 year with HbA1c less than or equal to 12%; * Socially insured ; * Having given their written consent to participate in the research, as well as that of their legal guardians; * Willing to comply with all research procedures and duration. Exclusion Criteria: * Clinically significant microvascular complications: nephropathy (estimated glomerular filtration rate less than 40 ml/min), neuropathy or severe proliferative retinopathy as assessed by the investigator; * Recent acute macrovascular event (\< 3 months), e.g. acute coronary syndrome or cardiac surgery; * Abnormal blood picture and/or anemia; * Current pregnancy; * Other serious medical condition likely to interfere with study participation or ability to complete exercise periods in the judgment of the investigator (e.g., orthopedic limitation); * Inability to receive informed information; * Inability to participate in the entire study; * Lack of social security coverage; * Refusal to sign the consent form.
Where this trial is running
Loos, Nord
- Eurasport — Loos, Nord, France (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.